PubRank

Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics

Clinical Trial ID NCT00870012

PubWeight™ 2.12‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00870012

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997 665.31
2 Diversity of the human intestinal microbial flora. Science 2005 49.64
3 An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006 44.35
4 Microbial ecology: human gut microbes associated with obesity. Nature 2006 36.98
5 Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005 33.66
6 The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004 26.56
7 The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis. Nucleic Acids Res 2005 24.85
8 A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006 10.97
9 Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002 10.78
10 Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006 9.34
11 A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003 8.00
12 Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002 6.62
13 Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007 5.99
14 Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005 4.86
15 Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 2007 3.02
16 Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007 2.09
17 Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 2004 2.06
18 The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology 2007 1.92
19 Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology 1990 1.59
20 Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. J Hepatol 2007 1.55
21 Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol 2013 1.18
22 Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice. Gastroenterology 2008 1.15
23 Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006 1.10
24 Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study. PLoS One 2013 1.04
25 Histological progression of non-alcoholic fatty liver disease in Chinese patients. Aliment Pharmacol Ther 2005 0.87
Next 100